Gilead Sciences: National Black HIV/AIDS Awareness Day

NORTHAMPTON, MA / ACCESSWIRE / February 29, 2024 / This year's theme for National Black HIV/AIDS Awareness Day is "Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities." We spoke with C. Virginia Fields, President and CEO of National Black Leadership Commission on Health (Black Health), a Gilead grantee, about how together, we can take action toward meaningful change.

We commend Virginia and our many community partners for continuing to honor and advance the decades of progress that Black communities have made in HIV.

Learn more: https://gilead.inc/487PjBu

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: [email protected]

SOURCE: Gilead Sciences

You May Also Be Interested In

• CSRHub Announces Strategic Partnership With SG Analytics, a Straive Company
• Skillprint Flow Launches to Turn Gameplay into Human-Performance Data for AI, Creating a New Revenue Stream for Game Studios
• Mantle Vault Expands to DeFi, Bringing Institutional-Grade RWA Yield On-chain with Grove, CIAN, and Fluxion